CHMP5 and COVID-19: Of the several COVID-19 vaccines that have received regulatory approval, two mRNA vaccines expressing the spike protein are predominantly used; the first being the BNT162b2 manufactured by BioNTech-Pfizer, and the second mRNA-1273 manufactured by Moderna-NIAID12.